menu
    • menu

    Company profile for Bioprojet Pharma

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    In 1992, BIOPROJET shareholders created BIOPROJET PHARMA, a pharmaceutical company. Both companies have the same management.The activity of BIOPROJET PHARMA is centered on marketing in France of pharmaceutical compounds mostly issued from BIOPROJET’s research and development. Tiorfan® (Racecadotril) capsules was launched in France in 1993 for adult and Tiorfan® (Racecadotril) granulated powder in sachet in 2000 for childre...
    In 1992, BIOPROJET shareholders created BIOPROJET PHARMA, a pharmaceutical company. Both companies have the same management.The activity of BIOPROJET PHARMA is centered on marketing in France of pharmaceutical compounds mostly issued from BIOPROJET’s research and development. Tiorfan® (Racecadotril) capsules was launched in France in 1993 for adult and Tiorfan® (Racecadotril) granulated powder in sachet in 2000 for children and infants. Since 2002 BIOPROJET PHARMA has gradually extended the geographic coverage of Tiorfan®/Hidrasec® (Racecadotril) to major European markets and overseas markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bioprojet PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    9, rue Rameau-75002, Paris
    Telephone
    Telephone
    +33 (0)1 47 03 66 33
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.bioprojet.fr/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bioprojet: WAKIX receives approval for the treatment of narcolepsy
    Bioprojet: WAKIX receives approval for the treatment of narcolepsy

    15 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/bioprojet-wakix-pitolisant-receives-approval-for-the-treatment-of-narcolepsy-in-children-over-6-years-of-age-a-rare-under-diagnosed-condition-301772642.html

    PR NEWSWIRE
    15 Mar 2023
    Share Share
    EMA nod for excessive daytime sleepiness med Ozawade
    EMA nod for excessive daytime sleepiness med Ozawade

    28 Oct 2021

    // Lucy Parsons PHARMATIMES

    http://www.pharmatimes.com/news/ema_nod_for_excessive_daytime_sleepiness_med_ozawade_1382343

    Lucy Parsons PHARMATIMES
    28 Oct 2021
    Share Share
    Bioprojet's Ozawade (pitolisant) Receives Approval in Europe
    Bioprojet's Ozawade (pitolisant) Receives Approval in Europe

    01 Sep 2021

    // EMA

    https://www.ema.europa.eu/en/medicines/human/EPAR/ozawade

    EMA
    01 Sep 2021
    Share Share
    Harmony Biosciences To Present New Data Analyses For WAKIX At The SLEEP 2021
    Harmony Biosciences To Present New Data Analyses For WAKIX At The SLEEP 2021

    07 Jun 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/harmony-biosciences-to-present-new-data-analyses-for-wakix-pitolisant-at-the-sleep-2021-annual-meeting-301306273.html

    PRNEWSWIRE
    07 Jun 2021
    Share Share
    Bioprojet's Wakix(pitolisant) receives market authorisation in EU for Narcolepsy
    Bioprojet's Wakix(pitolisant) receives market authorisation in EU for Narcolepsy

    13 Apr 2016

    // EMA

    https://www.pharmacompass.com/pdf/news/bioprojets-wakixpitolisant-receives-market-authorisation-in-eu-for-narcolepsy-1460632888.pdf

    EMA
    13 Apr 2016
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search